Seven life sciences companies have secured promotions across key Australian market benchmarks in the latest quarterly S&P/ASX index rebalance, reflecting recent shifts in market capitalization and trading activity.
While these seven life sciences stocks advanced to higher-tier indices, the quarterly adjustments also resulted in several other sector peers being demoted or removed from the indices altogether.
Source Attribution: Article content originally reported by Tim Boreham. Read original story coverage on Tim Boreham →
